Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Reigner

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Clinical Pharmacology and Therapeutics|August 18, 2016
Bottom-up Meets Top-down: Complementary Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling for Regulatory Approval of a Dosing Algorithm of Valganciclovir in Very Young ChildrenK Jorga, C Chavanne, N Frey, et al.
Bulletin De L'Association Des Anatomistes|March 1, 1995
[Angiographic study of collateral circulation in coronary occlusion]O Regnard, J B Subayi, X Papon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumorsJ Cassidy, L Dirix, D Bissett, et al.
Investigational New Drugs|November 11, 1999
A human capecitabine excretion balance and pharmacokinetic study after administration of a single oral dose of 14C-labelled drugI R Judson, P J Beale, J M Trigo, et al.
Cancer Chemotherapy and Pharmacology|February 7, 2001
Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patientsJ Schüller, J Cassidy, E Dumont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancerM Mackean, A Planting, C Twelves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolitesC Twelves, R Glynne-Jones, J Cassidy, et al.
British Journal of Cancer|July 7, 2000
A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumoursL C Pronk, P Vasey, A Sparreboom, et al.
Cancer Chemotherapy and Pharmacology|March 11, 1999
Influence of the antacid Maalox on the pharmacokinetics of capecitabine in cancer patientsB Reigner, S Clive, J Cassidy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patientsB Reigner, J Verweij, L Dirix, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Clinical Pharmacology and Therapeutics|August 18, 2016
Bottom-up Meets Top-down: Complementary Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling for Regulatory Approval of a Dosing Algorithm of Valganciclovir in Very Young ChildrenK Jorga, C Chavanne, N Frey, et al.
Bulletin De L'Association Des Anatomistes|March 1, 1995
[Angiographic study of collateral circulation in coronary occlusion]O Regnard, J B Subayi, X Papon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumorsJ Cassidy, L Dirix, D Bissett, et al.
Investigational New Drugs|November 11, 1999
A human capecitabine excretion balance and pharmacokinetic study after administration of a single oral dose of 14C-labelled drugI R Judson, P J Beale, J M Trigo, et al.
Cancer Chemotherapy and Pharmacology|February 7, 2001
Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patientsJ Schüller, J Cassidy, E Dumont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancerM Mackean, A Planting, C Twelves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolitesC Twelves, R Glynne-Jones, J Cassidy, et al.
British Journal of Cancer|July 7, 2000
A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumoursL C Pronk, P Vasey, A Sparreboom, et al.
Cancer Chemotherapy and Pharmacology|March 11, 1999
Influence of the antacid Maalox on the pharmacokinetics of capecitabine in cancer patientsB Reigner, S Clive, J Cassidy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patientsB Reigner, J Verweij, L Dirix, et al.
Pageof 4